+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Autoimmune Disease Diagnostics Market Research Report by Type, Indication, Test, Product, End-user, and Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 5014101
  • Report
  • October 2021
  • Region: Global
  • 187 Pages
  • 360iResearch™
UP TO OFF
until Jan 01st 2022
Global Autoimmune Disease Diagnostics Market is Projected to Reach USD 6,573.64 Million by 2026, Registering a CAGR of 8.84%

FEATURED COMPANIES

  • Abbott Laboratories
  • Beckman Coulter, Inc.
  • Exagen Inc.
  • Novartis AG
  • Sanofi S.A.
  • SQI Diagnostics
The Global Autoimmune Disease Diagnostics Market size was estimated at USD 3,952.56 million in 2020, is expected to reach USD 4,294.85 million in 2021, and projected to grow at a CAGR of 8.84% reaching USD 6,573.64 million by 2026.



Market Statistics


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage


This research report categorizes the Autoimmune Disease Diagnostics to forecast the revenues and analyze the trends in each of the following sub-markets:

  • Based on Type, the market was studied across Localized Autoimmune Disease Diagnostics and Systemic Autoimmune Disease Diagnostics.
  • Based on Indication, the market was studied across Addison Disease, Celiac Disease, Dermatomyositis, Graves Disease, Hashimoto Thyroiditis, Multiple Sclerosis, Myasthenia Gravis, Pernicious Anemia, Reactive Arthritis, Rheumatoid Arthritis, Sjögren syndrome, Systemic Lupus Erythematosus, and Type I Diabetes.
  • Based on Test, the market was studied across Autoantibodies & Immunologic Test, Inflammatory Marker, and Routine Laboratory Test. The Autoantibodies & Immunologic Test is further studied across Anti-cyclic Citrullinated Peptide, Antinuclear Antibody, C-reactive Protein, Erythrocyte Sedimentation Rate, Rheumatoid Factor, and Thyroid Antibody Tests. The Thyroid Antibody Tests is further studied across T3, T3RU, T4, and TSH.
  • Based on Product, the market was studied across Consumable & Assay Kit and Diagnostic Instrument.
  • Based on End-user, the market was studied across Clinical Laboratory and Hospital.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. The analyst's ongoing research amplifies their research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Autoimmune Disease Diagnostics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Autoimmune Disease Diagnostics Market, including Abbott Laboratories, AESKU.GROUP GmbH & Co. KG, AstraZeneca PLC, Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., BioAgilytix Labs, Biogenuix Medsystems Private Limited, bioMerieux SA, EUROIMMUN Medical Laboratory Diagnostics AG, Exagen Inc., F. Hoffmann-La Roche AG, Hemagen Diagnostics, Inc., Novartis AG, Pfizer Inc., Quest Diagnostics, Sanofi S.A., SD BioSensor Inc., Siemens Healthineers AG, SQI Diagnostics, Thermo Fisher Scientific Inc., Trinity Biotech PLC, and Werfen Group.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Autoimmune Disease Diagnostics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Autoimmune Disease Diagnostics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Autoimmune Disease Diagnostics Market?
4. What is the competitive strategic window for opportunities in the Global Autoimmune Disease Diagnostics Market?
5. What are the technology trends and regulatory frameworks in the Global Autoimmune Disease Diagnostics Market?
6. What is the market share of the leading vendors in the Global Autoimmune Disease Diagnostics Market?
7. What modes and strategic moves are considered suitable for entering the Global Autoimmune Disease Diagnostics Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Beckman Coulter, Inc.
  • Exagen Inc.
  • Novartis AG
  • Sanofi S.A.
  • SQI Diagnostics
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.2.1. Increasing Incidence of Autoimmune Diseases such as Rheumatoid Arthritis, Graves' disease and Hashimoto's thyroiditis
5.2.2. Awareness Among Public About Autoimmune Diseases and Favorable Government Initiatives
5.2.3. Improved Laboratory Techniques and Automation
5.3. Restraints
5.3.1. High Frequency of False Positive Results
5.3.2. Slow Turnaround Time for Diagnostic Test
5.4. Opportunities
5.4.1. Adoption of Biosensors for Autoimmune Disease Diagnosis
5.4.2. Strategic Partnerships Between Physicians and Clinical Laboratories
5.4.3. Potential Growth in Reagent Rental Agreements and Collaboration Activities
5.5. Challenges
5.5.1. Cost associated with the diagnosis process

6. Autoimmune Disease Diagnostics Market, by Type
6.1. Introduction
6.2. Localized Autoimmune Disease Diagnostics
6.3. Systemic Autoimmune Disease Diagnostics

7. Autoimmune Disease Diagnostics Market, by Indication
7.1. Introduction
7.2. Addison Disease
7.3. Celiac Disease
7.4. Dermatomyositis
7.5. Graves Disease
7.6. Hashimoto Thyroiditis
7.7. Multiple Sclerosis
7.8. Myasthenia Gravis
7.9. Pernicious Anemia
7.10. Reactive Arthritis
7.11. Rheumatoid Arthritis
7.12. Sjögren syndrome
7.13. Systemic Lupus Erythematosus
7.14. Type I Diabetes

8. Autoimmune Disease Diagnostics Market, by Test
8.1. Introduction
8.2. Autoantibodies & Immunologic Test
8.2.1. Anti-cyclic Citrullinated Peptide
8.2.2. Antinuclear Antibody
8.2.3. C-reactive Protein
8.2.4. Erythrocyte Sedimentation Rate
8.2.5. Rheumatoid Factor
8.2.6. Thyroid Antibody Tests
8.2.6.1. T3
8.2.6.2. T3RU
8.2.6.3. T4
8.2.6.4. TSH
8.3. Inflammatory Marker
8.4. Routine Laboratory Test

9. Autoimmune Disease Diagnostics Market, by Product
9.1. Introduction
9.2. Consumable & Assay Kit
9.3. Diagnostic Instrument

10. Autoimmune Disease Diagnostics Market, by End-user
10.1. Introduction
10.2. Clinical Laboratory
10.3. Hospital

11. Americas Autoimmune Disease Diagnostics Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Autoimmune Disease Diagnostics Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Thailand

13. Europe, Middle East & Africa Autoimmune Disease Diagnostics Market
13.1. Introduction
13.2. France
13.3. Germany
13.4. Italy
13.5. Netherlands
13.6. Qatar
13.7. Russia
13.8. Saudi Arabia
13.9. South Africa
13.10. Spain
13.11. United Arab Emirates
13.12. United Kingdom

14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis
14.3. Market Share Analysis, by Key Player
14.4. Competitive Scenario
14.4.1. Merger & Acquisition
14.4.2. Agreement, Collaboration, & Partnership
14.4.3. New Product Launch & Enhancement
14.4.4. Investment & Funding
14.4.5. Award, Recognition, & Expansion

15. Company Usability Profiles
15.1. Abbott Laboratories
15.2. AESKU.GROUP GmbH & Co. KG
15.3. AstraZeneca PLC
15.4. Beckman Coulter, Inc.
15.5. Bio-Rad Laboratories, Inc.
15.6. BioAgilytix Labs
15.7. Biogenuix Medsystems Private Limited
15.8. bioMerieux SA
15.9. EUROIMMUN Medical Laboratory Diagnostics AG
15.10. Exagen Inc.
15.11. F. Hoffmann-La Roche AG
15.12. Hemagen Diagnostics, Inc.
15.13. Novartis AG
15.14. Pfizer Inc.
15.15. Quest Diagnostics
15.16. Sanofi S.A.
15.17. SD BioSensor Inc.
15.18. Siemens Healthineers AG
15.19. SQI Diagnostics
15.20. Thermo Fisher Scientific Inc.
15.21. Trinity Biotech PLC
15.22. Werfen Group

16. Appendix
16.1. Discussion Guide
16.2. License & Pricing

List of Figures
Figure 1. Global Autoimmune Disease Diagnostics Market Size, 2020 vs 2026 (USD Million)
Figure 2. Global Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Figure 3. Global Autoimmune Disease Diagnostics Market: Market Dynamics
Figure 4. Global Autoimmune Disease Diagnostics Market Size, by Type, 2020 vs 2026 (%)
Figure 5. Global Autoimmune Disease Diagnostics Market Size, by Type, 2020 vs 2026 (USD Million)
Figure 6. Competitive Strategic Window for Global Autoimmune Disease Diagnostics Market Size, by Type, 2026
Figure 7. Global Autoimmune Disease Diagnostics Market Size, by Localized Autoimmune Disease Diagnostics, 2018-2026 (USD Million)
Figure 8. Global Autoimmune Disease Diagnostics Market Size, by Localized Autoimmune Disease Diagnostics, by Region, 2020 vs 2026 (USD Million)
Figure 9. Global Autoimmune Disease Diagnostics Market Size, by Systemic Autoimmune Disease Diagnostics, 2018-2026 (USD Million)
Figure 10. Global Autoimmune Disease Diagnostics Market Size, by Systemic Autoimmune Disease Diagnostics, by Region, 2020 vs 2026 (USD Million)
Figure 11. Global Autoimmune Disease Diagnostics Market Size, by Indication, 2020 vs 2026 (%)
Figure 12. Global Autoimmune Disease Diagnostics Market Size, by Indication, 2020 vs 2026 (USD Million)
Figure 13. Competitive Strategic Window for Global Autoimmune Disease Diagnostics Market Size, by Indication, 2026
Figure 14. Global Autoimmune Disease Diagnostics Market Size, by Addison Disease, 2018-2026 (USD Million)
Figure 15. Global Autoimmune Disease Diagnostics Market Size, by Addison Disease, by Region, 2020 vs 2026 (USD Million)
Figure 16. Global Autoimmune Disease Diagnostics Market Size, by Celiac Disease, 2018-2026 (USD Million)
Figure 17. Global Autoimmune Disease Diagnostics Market Size, by Celiac Disease, by Region, 2020 vs 2026 (USD Million)
Figure 18. Global Autoimmune Disease Diagnostics Market Size, by Dermatomyositis, 2018-2026 (USD Million)
Figure 19. Global Autoimmune Disease Diagnostics Market Size, by Dermatomyositis, by Region, 2020 vs 2026 (USD Million)
Figure 20. Global Autoimmune Disease Diagnostics Market Size, by Graves Disease, 2018-2026 (USD Million)
Figure 21. Global Autoimmune Disease Diagnostics Market Size, by Graves Disease, by Region, 2020 vs 2026 (USD Million)
Figure 22. Global Autoimmune Disease Diagnostics Market Size, by Hashimoto Thyroiditis, 2018-2026 (USD Million)
Figure 23. Global Autoimmune Disease Diagnostics Market Size, by Hashimoto Thyroiditis, by Region, 2020 vs 2026 (USD Million)
Figure 24. Global Autoimmune Disease Diagnostics Market Size, by Multiple Sclerosis, 2018-2026 (USD Million)
Figure 25. Global Autoimmune Disease Diagnostics Market Size, by Multiple Sclerosis, by Region, 2020 vs 2026 (USD Million)
Figure 26. Global Autoimmune Disease Diagnostics Market Size, by Myasthenia Gravis, 2018-2026 (USD Million)
Figure 27. Global Autoimmune Disease Diagnostics Market Size, by Myasthenia Gravis, by Region, 2020 vs 2026 (USD Million)
Figure 28. Global Autoimmune Disease Diagnostics Market Size, by Pernicious Anemia, 2018-2026 (USD Million)
Figure 29. Global Autoimmune Disease Diagnostics Market Size, by Pernicious Anemia, by Region, 2020 vs 2026 (USD Million)
Figure 30. Global Autoimmune Disease Diagnostics Market Size, by Reactive Arthritis, 2018-2026 (USD Million)
Figure 31. Global Autoimmune Disease Diagnostics Market Size, by Reactive Arthritis, by Region, 2020 vs 2026 (USD Million)
Figure 32. Global Autoimmune Disease Diagnostics Market Size, by Rheumatoid Arthritis, 2018-2026 (USD Million)
Figure 33. Global Autoimmune Disease Diagnostics Market Size, by Rheumatoid Arthritis, by Region, 2020 vs 2026 (USD Million)
Figure 34. Global Autoimmune Disease Diagnostics Market Size, by Sjögren Syndrome, 2018-2026 (USD Million)
Figure 35. Global Autoimmune Disease Diagnostics Market Size, by Sjögren Syndrome, by Region, 2020 vs 2026 (USD Million)
Figure 36. Global Autoimmune Disease Diagnostics Market Size, by Systemic Lupus Erythematosus, 2018-2026 (USD Million)
Figure 37. Global Autoimmune Disease Diagnostics Market Size, by Systemic Lupus Erythematosus, by Region, 2020 vs 2026 (USD Million)
Figure 38. Global Autoimmune Disease Diagnostics Market Size, by Type I Diabetes, 2018-2026 (USD Million)
Figure 39. Global Autoimmune Disease Diagnostics Market Size, by Type I Diabetes, by Region, 2020 vs 2026 (USD Million)
Figure 40. Global Autoimmune Disease Diagnostics Market Size, by Test, 2020 vs 2026 (%)
Figure 41. Global Autoimmune Disease Diagnostics Market Size, by Test, 2020 vs 2026 (USD Million)
Figure 42. Competitive Strategic Window for Global Autoimmune Disease Diagnostics Market Size, by Test, 2026
Figure 43. Global Autoimmune Disease Diagnostics Market Size, by Autoantibodies & Immunologic Test, 2018-2026 (USD Million)
Figure 44. Global Autoimmune Disease Diagnostics Market Size, by Autoantibodies & Immunologic Test, by Region, 2020 vs 2026 (USD Million)
Figure 45. Global Autoimmune Disease Diagnostics Market Size, by Anti-Cyclic Citrullinated Peptide, 2018-2026 (USD Million)
Figure 46. Global Autoimmune Disease Diagnostics Market Size, by Anti-Cyclic Citrullinated Peptide, by Region, 2020 vs 2026 (USD Million)
Figure 47. Global Autoimmune Disease Diagnostics Market Size, by Antinuclear Antibody, 2018-2026 (USD Million)
Figure 48. Global Autoimmune Disease Diagnostics Market Size, by Antinuclear Antibody, by Region, 2020 vs 2026 (USD Million)
Figure 49. Global Autoimmune Disease Diagnostics Market Size, by C-Reactive Protein, 2018-2026 (USD Million)
Figure 50. Global Autoimmune Disease Diagnostics Market Size, by C-Reactive Protein, by Region, 2020 vs 2026 (USD Million)
Figure 51. Global Autoimmune Disease Diagnostics Market Size, by Erythrocyte Sedimentation Rate, 2018-2026 (USD Million)
Figure 52. Global Autoimmune Disease Diagnostics Market Size, by Erythrocyte Sedimentation Rate, by Region, 2020 vs 2026 (USD Million)
Figure 53. Global Autoimmune Disease Diagnostics Market Size, by Rheumatoid Factor, 2018-2026 (USD Million)
Figure 54. Global Autoimmune Disease Diagnostics Market Size, by Rheumatoid Factor, by Region, 2020 vs 2026 (USD Million)
Figure 55. Global Autoimmune Disease Diagnostics Market Size, by Thyroid Antibody Tests, 2018-2026 (USD Million)
Figure 56. Global Autoimmune Disease Diagnostics Market Size, by Thyroid Antibody Tests, by Region, 2020 vs 2026 (USD Million)
Figure 57. Global Autoimmune Disease Diagnostics Market Size, by T3, 2018-2026 (USD Million)
Figure 58. Global Autoimmune Disease Diagnostics Market Size, by T3, by Region, 2020 vs 2026 (USD Million)
Figure 59. Global Autoimmune Disease Diagnostics Market Size, by T3Ru, 2018-2026 (USD Million)
Figure 60. Global Autoimmune Disease Diagnostics Market Size, by T3Ru, by Region, 2020 vs 2026 (USD Million)
Figure 61. Global Autoimmune Disease Diagnostics Market Size, by T4, 2018-2026 (USD Million)
Figure 62. Global Autoimmune Disease Diagnostics Market Size, by T4, by Region, 2020 vs 2026 (USD Million)
Figure 63. Global Autoimmune Disease Diagnostics Market Size, by Tsh, 2018-2026 (USD Million)
Figure 64. Global Autoimmune Disease Diagnostics Market Size, by Tsh, by Region, 2020 vs 2026 (USD Million)
Figure 65. Global Autoimmune Disease Diagnostics Market Size, by Inflammatory Marker, 2018-2026 (USD Million)
Figure 66. Global Autoimmune Disease Diagnostics Market Size, by Inflammatory Marker, by Region, 2020 vs 2026 (USD Million)
Figure 67. Global Autoimmune Disease Diagnostics Market Size, by Routine Laboratory Test, 2018-2026 (USD Million)
Figure 68. Global Autoimmune Disease Diagnostics Market Size, by Routine Laboratory Test, by Region, 2020 vs 2026 (USD Million)
Figure 69. Global Autoimmune Disease Diagnostics Market Size, by Product, 2020 vs 2026 (%)
Figure 70. Global Autoimmune Disease Diagnostics Market Size, by Product, 2020 vs 2026 (USD Million)
Figure 71. Competitive Strategic Window for Global Autoimmune Disease Diagnostics Market Size, by Product, 2026
Figure 72. Global Autoimmune Disease Diagnostics Market Size, by Consumable & Assay Kit, 2018-2026 (USD Million)
Figure 73. Global Autoimmune Disease Diagnostics Market Size, by Consumable & Assay Kit, by Region, 2020 vs 2026 (USD Million)
Figure 74. Global Autoimmune Disease Diagnostics Market Size, by Diagnostic Instrument, 2018-2026 (USD Million)
Figure 75. Global Autoimmune Disease Diagnostics Market Size, by Diagnostic Instrument, by Region, 2020 vs 2026 (USD Million)
Figure 76. Global Autoimmune Disease Diagnostics Market Size, by End-user, 2020 vs 2026 (%)
Figure 77. Global Autoimmune Disease Diagnostics Market Size, by End-user, 2020 vs 2026 (USD Million)
Figure 78. Competitive Strategic Window for Global Autoimmune Disease Diagnostics Market Size, by End-user, 2026
Figure 79. Global Autoimmune Disease Diagnostics Market Size, by Clinical Laboratory, 2018-2026 (USD Million)
Figure 80. Global Autoimmune Disease Diagnostics Market Size, by Clinical Laboratory, by Region, 2020 vs 2026 (USD Million)
Figure 81. Global Autoimmune Disease Diagnostics Market Size, by Hospital, 2018-2026 (USD Million)
Figure 82. Global Autoimmune Disease Diagnostics Market Size, by Hospital, by Region, 2020 vs 2026 (USD Million)
Figure 83. Americas Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Figure 84. Argentina Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Figure 85. Brazil Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Figure 86. Canada Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Figure 87. Mexico Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Figure 88. United States Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Figure 89. Asia-Pacific Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Figure 90. Australia Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Figure 91. China Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Figure 92. India Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Figure 93. Indonesia Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Figure 94. Japan Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Figure 95. Malaysia Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Figure 96. Philippines Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Figure 97. Singapore Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Figure 98. South Korea Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Figure 99. Thailand Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Figure 100. Europe, Middle East & Africa Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Figure 101. France Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Figure 102. Germany Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Figure 103. Italy Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Figure 104. Netherlands Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Figure 105. Qatar Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Figure 106. Russia Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Figure 107. Saudi Arabia Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Figure 108. South Africa Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Figure 109. Spain Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Figure 110. United Arab Emirates Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Figure 111. United Kingdom Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Figure 112. Global Autoimmune Disease Diagnostics Market: FPNV Positioning Matrix
Figure 113. Global Autoimmune Disease Diagnostics Market: Share, by Key Player, 2020
Figure 114. Competitive Scenario Analysis in Global Autoimmune Disease Diagnostics Market, by Type

List of Tables
Table 1. Global Autoimmune Disease Diagnostics Market: Market Segmentation & Coverage
Table 2. United States Dollar Exchange Rate, 2016–2020
Table 3. Global Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Table 4. Global Autoimmune Disease Diagnostics Market Size, by Type, 2018-2026 (USD Million)
Table 5. Global Autoimmune Disease Diagnostics Market Size, by Localized Autoimmune Disease Diagnostics, by Region, 2018-2026 (USD Million)
Table 6. Global Autoimmune Disease Diagnostics Market Size, by Systemic Autoimmune Disease Diagnostics, by Region, 2018-2026 (USD Million)
Table 7. Global Autoimmune Disease Diagnostics Market Size, by Indication, 2018-2026 (USD Million)
Table 8. Global Autoimmune Disease Diagnostics Market Size, by Addison Disease, by Region, 2018-2026 (USD Million)
Table 9. Global Autoimmune Disease Diagnostics Market Size, by Celiac Disease, by Region, 2018-2026 (USD Million)
Table 10. Global Autoimmune Disease Diagnostics Market Size, by Dermatomyositis, by Region, 2018-2026 (USD Million)
Table 11. Global Autoimmune Disease Diagnostics Market Size, by Graves Disease, by Region, 2018-2026 (USD Million)
Table 12. Global Autoimmune Disease Diagnostics Market Size, by Hashimoto Thyroiditis, by Region, 2018-2026 (USD Million)
Table 13. Global Autoimmune Disease Diagnostics Market Size, by Multiple Sclerosis, by Region, 2018-2026 (USD Million)
Table 14. Global Autoimmune Disease Diagnostics Market Size, by Myasthenia Gravis, by Region, 2018-2026 (USD Million)
Table 15. Global Autoimmune Disease Diagnostics Market Size, by Pernicious Anemia, by Region, 2018-2026 (USD Million)
Table 16. Global Autoimmune Disease Diagnostics Market Size, by Reactive Arthritis, by Region, 2018-2026 (USD Million)
Table 17. Global Autoimmune Disease Diagnostics Market Size, by Rheumatoid Arthritis, by Region, 2018-2026 (USD Million)
Table 18. Global Autoimmune Disease Diagnostics Market Size, by Sjögren Syndrome, by Region, 2018-2026 (USD Million)
Table 19. Global Autoimmune Disease Diagnostics Market Size, by Systemic Lupus Erythematosus, by Region, 2018-2026 (USD Million)
Table 20. Global Autoimmune Disease Diagnostics Market Size, by Type I Diabetes, by Region, 2018-2026 (USD Million)
Table 21. Global Autoimmune Disease Diagnostics Market Size, by Test, 2018-2026 (USD Million)
Table 22. Global Autoimmune Disease Diagnostics Market Size, by Autoantibodies & Immunologic Test, by Region, 2018-2026 (USD Million)
Table 23. Global Autoimmune Disease Diagnostics Market Size, by Anti-Cyclic Citrullinated Peptide, by Region, 2018-2026 (USD Million)
Table 24. Global Autoimmune Disease Diagnostics Market Size, by Antinuclear Antibody, by Region, 2018-2026 (USD Million)
Table 25. Global Autoimmune Disease Diagnostics Market Size, by C-Reactive Protein, by Region, 2018-2026 (USD Million)
Table 26. Global Autoimmune Disease Diagnostics Market Size, by Erythrocyte Sedimentation Rate, by Region, 2018-2026 (USD Million)
Table 27. Global Autoimmune Disease Diagnostics Market Size, by Rheumatoid Factor, by Region, 2018-2026 (USD Million)
Table 28. Global Autoimmune Disease Diagnostics Market Size, by Thyroid Antibody Tests, by Region, 2018-2026 (USD Million)
Table 29. Global Autoimmune Disease Diagnostics Market Size, by T3, by Region, 2018-2026 (USD Million)
Table 30. Global Autoimmune Disease Diagnostics Market Size, by T3Ru, by Region, 2018-2026 (USD Million)
Table 31. Global Autoimmune Disease Diagnostics Market Size, by T4, by Region, 2018-2026 (USD Million)
Table 32. Global Autoimmune Disease Diagnostics Market Size, by Tsh, by Region, 2018-2026 (USD Million)
Table 33. Global Autoimmune Disease Diagnostics Market Size, by Inflammatory Marker, by Region, 2018-2026 (USD Million)
Table 34. Global Autoimmune Disease Diagnostics Market Size, by Routine Laboratory Test, by Region, 2018-2026 (USD Million)
Table 35. Global Autoimmune Disease Diagnostics Market Size, by Product, 2018-2026 (USD Million)
Table 36. Global Autoimmune Disease Diagnostics Market Size, by Consumable & Assay Kit, by Region, 2018-2026 (USD Million)
Table 37. Global Autoimmune Disease Diagnostics Market Size, by Diagnostic Instrument, by Region, 2018-2026 (USD Million)
Table 38. Global Autoimmune Disease Diagnostics Market Size, by End-user, 2018-2026 (USD Million)
Table 39. Global Autoimmune Disease Diagnostics Market Size, by Clinical Laboratory, by Region, 2018-2026 (USD Million)
Table 40. Global Autoimmune Disease Diagnostics Market Size, by Hospital, by Region, 2018-2026 (USD Million)
Table 41. Americas Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Table 42. Argentina Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Table 43. Brazil Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Table 44. Canada Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Table 45. Mexico Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Table 46. United States Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Table 47. Asia-Pacific Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Table 48. Australia Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Table 49. China Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Table 50. India Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Table 51. Indonesia Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Table 52. Japan Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Table 53. Malaysia Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Table 54. Philippines Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Table 55. Singapore Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Table 56. South Korea Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Table 57. Thailand Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Table 58. Europe, Middle East & Africa Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Table 59. France Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Table 60. Germany Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Table 61. Italy Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Table 62. Netherlands Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Table 63. Qatar Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Table 64. Russia Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Table 65. Saudi Arabia Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Table 66. South Africa Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Table 67. Spain Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Table 68. United Arab Emirates Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Table 69. United Kingdom Autoimmune Disease Diagnostics Market Size, 2018-2026 (USD Million)
Table 70. Global Autoimmune Disease Diagnostics Market: Scores
Table 71. Global Autoimmune Disease Diagnostics Market: Business Strategy
Table 72. Global Autoimmune Disease Diagnostics Market: Product Satisfaction
Table 73. Global Autoimmune Disease Diagnostics Market: Ranking
Table 74. Global Autoimmune Disease Diagnostics Market: Share, by Key Player, 2020
Table 75. Global Autoimmune Disease Diagnostics Market: Merger & Acquisition
Table 76. Global Autoimmune Disease Diagnostics Market: Agreement, Collaboration & Partnership
Table 77. Global Autoimmune Disease Diagnostics Market: New Product Launch & Enhancement
Table 78. Global Autoimmune Disease Diagnostics Market: Investment & Funding
Table 79. Global Autoimmune Disease Diagnostics Market: Award, Recognition & Expansion
Table 80. Global Autoimmune Disease Diagnostics Market: License & Pricing
Note: Product cover images may vary from those shown
  • Abbott Laboratories
  • AESKU.GROUP GmbH & Co. KG
  • AstraZeneca PLC
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories, Inc.
  • BioAgilytix Labs
  • Biogenuix Medsystems Private Limited
  • bioMerieux SA
  • EUROIMMUN Medical Laboratory Diagnostics AG
  • Exagen Inc.
  • F. Hoffmann-La Roche AG
  • Hemagen Diagnostics, Inc.
  • Novartis AG
  • Pfizer Inc.
  • Quest Diagnostics
  • Sanofi S.A.
  • SD BioSensor Inc.
  • Siemens Healthineers AG
  • SQI Diagnostics
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech PLC
  • Werfen Group
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll